|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Depreciation and amortization | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Interest from amortization of loan issuance costs | |||||
| Amortization of fair value of loan | |||||
| Loss (gain) on disposal of property and equipment | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value of acquisition earnout liabilities | |||||
| Loss on disposal of property and equipment | |||||
| Change in fair value of warrant liability | |||||
| Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | |||||
| Amorphous Materials, LLC (“AML”) | |||||
| Total business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | |||||
| Earnout payment for acquisition of G5, net of financing portion | |||||
| (Gain) loss on disposal of property and equipment | |||||
| Stock-based compensation on stock options, RSUs & RSAs, net | |||||
| Provision for credit losses | |||||
| Change in operating lease assets and liabilities | |||||
| Inventory write-offs to allowance | |||||
| Deferred taxes | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Trade accounts receivable | |||||
| Other current assets | |||||
| Inventories | |||||
| Prepaid expenses and deposits | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition of Visimid Technologies, net of cash acquired | |||||
| Proceeds from sale of equipment | |||||
| Proceeds from sale-leaseback of equipment | |||||
| Acquisition of G5 | |||||
| Acquisition of Visimid, net of cash acquired | |||||
| Acquisition of G5 Infrared | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from sale of common stock from Employee Stock Purchase Plan | |||||
| Proceeds from issuance of common stock under public equity placement | |||||
| Proceeds from issuance of common stock under private equity placement, net of fees | |||||
| Proceeds from issuance of preferred stock under private equity placement, net of fees | |||||
| Proceeds from issuance of warrants under private equity placement, net of fees | |||||
| Deferred payment for acquisition of Visimid | |||||
| Borrowings on loans payable | |||||
| Loan issuance costs | |||||
| Payments on loans payable | |||||
| Repayment of finance lease obligations | |||||
| Earnout payment for acquisition of G5, net of operating portion | |||||
| G5 Infrared | |||||
| Visimid Technologies | |||||
| Borrowings on loans payable | |||||
| Loan issuance costs | |||||
| Payments on loans payable | |||||
| Repayment of finance lease obligations | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate on cash and cash equivalents | |||||
| Change in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid in cash | |||||
| Income taxes paid | |||||
| Purchase of equipment through finance lease arrangements | |||||
| Equipment deposit paid in restricted stock | |||||
| Supplemental disclosure of non-cash investing & financing activities: | |||||
| Issuance of common stock for acquisition of Visimid | |||||
| Issuance of common stock for acquisition of G5 | |||||
| Accrual of earnout consideration for acquisition of G5 | |||||
| Purchase of equipment through finance lease arrangements | |||||
| Operating right-of-use assets acquired in exchange for operating lease liabilities | |||||
| Issuance of common stock for acquisition | |||||
| G5 Infrared | |||||
| Amorphous Materials, LLC (“AML”) | |||||
| Visimid Technologies | |||||
| Accrual of earnout consideration for acquisition | |||||
| G5 Infrared | |||||
| Amorphous Materials, LLC (“AML”) | |||||
| Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note | |||||
Loading...